NuVasive
Clinical trials sponsored by NuVasive, explained in plain language.
Now part of
Globus Medical, Inc.
GMED
NYSE
A medical device company focused on minimally invasive spinal surgery.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Spine surgery safety under the microscope: new study watches Real-World results Results expected Sep 2026 (estimated)
- New neck plate aims to stabilize spine after surgery Results expected Sep 2026 (estimated)